Despite the fact that biopharmaceuticals offer significant profit margins, innovator companies are plagued by high costs of development, complex production protocols and special procedures and equipment for fill / finish operations. Consequently, a number of drug manufacturers have demonstrated a preference for outsourcing fill / finish operations of such products.
An in-depth analysis of more than 490 grants that have been awarded to research institutes engaged in next generation immune checkpoint therapy-related projects, in the period between 2016 and 2019 (till November), including analysis based on important parameters, such as year of grant award, amount awarded, administration institute center, funding institute center, support period, type of grant application, purpose of grant award, grant mechanism, popular target immune checkpoints, responsible study section, focus area, prominent program officers, and type of recipient organizations. It also features a detailed analysis based on the types of target immune checkpoints and therapeutic areas, along with a multivariate grant attractiveness analysis based on parameters, such as grant amount, support period, type of grant application and number of disease indications under investigation
To order this 480+ page report, which features 350+ figures and 260+ tables, please visit this https://www.rootsanalysis.com/reports/256/request-sample.html
The USD 4.2 billion (by 2030) financial opportunity within the biologics fill / finish services market has been analyzed across the following segments:
The Biologics Fill / Finish Services Market, 2020-2030 report features the following companies, which we identified to be key players in this domain:
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Competitive Landscape
5. Company Competitiveness Analysis
6. Biologics Fill / Finish Service Providers in North America: Company Profiles
7. Biologics Fill / Finish Service Providers in Europe: Company Profiles
8. Biologics Fill / Finish Service Providers in Asia-Pacific: Company Profiles
9. Partnerships and Collaborations
10. Recent Expansions
11. Capacity Analysis
12. Demand Analysis
13. Biologics Manufacturing and Fill / Finish: Key Performance Indicator Analysis
14. Market Sizing and Opportunity Analysis
15. Future Growth Opportunities
16. Case Study: Robotic Systems in Fill / Finish Operations
17. Case Study: Ready-to-Use Packaging Components in Aseptic Fill / Finish Operations
18. Conclusion
19. Interview Transcripts
20. Appendix 1: Tabulated Data
21. Appendix 2: List of Companies and Organizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
- Real exam questions in PDF and Practice test format. Download dumps file instantly.
- Everyone wants to pass the exam in first try. Visit CertsAdvice website for an easy preparation of your exam
- Many small / macro molecule-based STING pathway modulators are currently being evaluated as monotherapies